Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Home

Showing results (51-60 of 231) with videos related to

Pageof 24
Sort By:
Expert Opinion on Pharmacotherapy|February 5, 2002
Insulin glargine: the first clinically useful extended-action insulin analogueS G Ashwell, P D Home
Drugs & Aging|November 1, 1993
Problems and pitfalls of sulphonylurea therapy in older patientsD A Robertson, P D Home
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1984
Problems and safety of continuous subcutaneous insulin infusionP D Home, S M Marshall
Diabetic Medicine : a Journal of the British Diabetic Association|March 1, 1986
Which pump?S M Marshall, P D Home
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1987
Appointments and turnover of consultants and senior registrars in diabetes and endocrinology in the UK, 1984 and 1985P D Home, W M Tunbridge
Diabetes Care|October 17, 1998
Optimal provision of daytime NPH insulin in patients using the insulin analog lisproA B Ahmed, P D Home
Diabetes, Obesity & Metabolism|June 21, 2013
A propensity score matched comparison of different insulin regimens 1 year after beginning insulin in people with type 2 diabetesN Freemantle, B Balkau, P D Home
Diabetic Medicine : a Journal of the British Diabetic Association|December 29, 2000
Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trialP D Home, A Lindholm, A Riis, et al.
Diabetes, Obesity & Metabolism|May 15, 2015
Biosimilar insulins: guidance for data interpretation by clinicians and usersL Heinemann, P D Home, M Hompesch
Diabetes Care|July 22, 2016
Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear?Francesco Giorgino, Philip D Home, Jaakko Tuomilehto
Pageof 24

Showing results (51-60 of 231) with videos related to

Sort By:
Pageof 24
Expert Opinion on Pharmacotherapy|February 5, 2002
Insulin glargine: the first clinically useful extended-action insulin analogueS G Ashwell, P D Home
Drugs & Aging|November 1, 1993
Problems and pitfalls of sulphonylurea therapy in older patientsD A Robertson, P D Home
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1984
Problems and safety of continuous subcutaneous insulin infusionP D Home, S M Marshall
Diabetic Medicine : a Journal of the British Diabetic Association|March 1, 1986
Which pump?S M Marshall, P D Home
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1987
Appointments and turnover of consultants and senior registrars in diabetes and endocrinology in the UK, 1984 and 1985P D Home, W M Tunbridge
Diabetes Care|October 17, 1998
Optimal provision of daytime NPH insulin in patients using the insulin analog lisproA B Ahmed, P D Home
Diabetes, Obesity & Metabolism|June 21, 2013
A propensity score matched comparison of different insulin regimens 1 year after beginning insulin in people with type 2 diabetesN Freemantle, B Balkau, P D Home
Diabetic Medicine : a Journal of the British Diabetic Association|December 29, 2000
Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trialP D Home, A Lindholm, A Riis, et al.
Diabetes, Obesity & Metabolism|May 15, 2015
Biosimilar insulins: guidance for data interpretation by clinicians and usersL Heinemann, P D Home, M Hompesch
Diabetes Care|July 22, 2016
Glucose Control and Vascular Outcomes in Type 2 Diabetes: Is the Picture Clear?Francesco Giorgino, Philip D Home, Jaakko Tuomilehto
Pageof 24